{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:15:11Z","timestamp":1790874911321,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ccm.2023.08.009","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:39:51Z","timestamp":1693553991000},"page":"159-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Health-Related Quality of Life Assessment in Sarcoidosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Marc A.","family":"Judson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ccm.2023.08.009_bib1","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1164\/rccm.202106-1366CI","article-title":"Management of advanced pulmonary sarcoidosis","volume":"205","author":"Gupta","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"11 Suppl","key":"10.1016\/j.ccm.2023.08.009_bib4","first-page":"47","article-title":"Measuring quality of life: 1995 update","volume":"9","author":"Cella","year":"1995","journal-title":"Oncology (Williston Park NY)"},{"issue":"26","key":"10.1016\/j.ccm.2023.08.009_bib5","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1056\/NEJMp0807461","article-title":"Culture shock--patient as icon, icon as patient","volume":"359","author":"Verghese","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccm.2015.08.014","article-title":"Quality of life assessment in sarcoidosis","volume":"36","author":"Judson","year":"2015","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib8","first-page":"280","article-title":"The indications for the treatment of sarcoidosis : well\u2019s Law","volume":"34","author":"Baughman","year":"2017","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib9","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib10","first-page":"27","article-title":"Presentation of sarcoidosis and outcome of pulmonary changes","volume":"29","author":"Romer","year":"1982","journal-title":"Dan Med Bull"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.009_bib11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1378\/chest.120.1.102","article-title":"Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis","volume":"120","author":"Baydur","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.009_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","article-title":"The three tiers of screening for sarcoidosis organ involvement","volume":"113","author":"Judson","year":"2016","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1034\/j.1399-3003.1999.13d03.x","article-title":"Association of fatigue with an acute phase response in sarcoidosis","volume":"13","author":"Drent","year":"1999","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11916-011-0180-8","article-title":"Sarcoidosis and small-fiber neuropathy","volume":"15","author":"Tavee","year":"2011","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccm.2015.08.010","article-title":"Cutaneous sarcoidosis","volume":"36","author":"Wanat","year":"2015","journal-title":"Clin Chest Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib17","first-page":"33","article-title":"Impact of pain in a Dutch sarcoidosis patient population","volume":"20","author":"Hoitsma","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-0030-1262216","article-title":"Quality of life in sarcoidosis: assessment and management","volume":"31","author":"De Vries","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000314225","article-title":"Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment","volume":"80","author":"Elfferich","year":"2010","journal-title":"Respiration; international review of thoracic diseases"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.161.4.755","article-title":"Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis","volume":"161","author":"Adams","year":"1985","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.009_bib21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1183\/09031936.00060612","article-title":"Established and experimental medical therapy of pulmonary sarcoidosis","volume":"41","author":"Baughman","year":"2013","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.rdc.2015.08.012","article-title":"Corticosteroids in sarcoidosis","volume":"42","author":"Judson","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.ccm.2023.08.009_bib23","doi-asserted-by":"crossref","first-page":"106081","DOI":"10.1016\/j.rmed.2020.106081","article-title":"Corticosteroid refractory sarcoidosis","volume":"171","author":"Goldman","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.009_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/JAA.S176026","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study","volume":"11","author":"Price","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MAJ.0b013e3181fe3eb2","article-title":"Impact of systemic corticosteroids on healthcare utilization in patients with sarcoidosis","volume":"341","author":"Ligon","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ccm.2023.08.009_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00141-2018","article-title":"Sarcoidosis: patient treatment priorities","volume":"4","author":"Baughman","year":"2018","journal-title":"ERJ open research"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00408-018-0144-4","article-title":"Needs, perceptions and education in sarcoidosis: a live interactive survey of patients and partners","volume":"196","author":"Moor","year":"2018","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCP.0000000000000602","article-title":"Patient perspectives in sarcoidosis","volume":"25","author":"van Helmondt","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2023.08.009_bib31","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","article-title":"Patient-reported outcomes to support medical product labeling claims: FDA perspective","volume":"10","author":"Patrick","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.ccm.2023.08.009_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","year":"2006","journal-title":"Health Qual Life Outcome"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-0037-1602589","article-title":"Quality of life in sarcoidosis","volume":"38","author":"Judson","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.08.009_bib34","doi-asserted-by":"crossref","first-page":"c186","DOI":"10.1136\/bmj.c186","article-title":"The routine use of patient reported outcome measures in healthcare settings","volume":"340","author":"Dawson","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1524-4733.2010.00702.x","article-title":"Constructing a conceptual framework of patient-reported outcomes for metastatic hormone-refractory prostate cancer","volume":"13","author":"Eton","year":"2010","journal-title":"Value Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Contr Clin Trials"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MCP.0b013e3283050a4f","article-title":"Quality of life evaluation in sarcoidosis: current status and future directions","volume":"14","author":"Victorson","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"12 Suppl 2","key":"10.1016\/j.ccm.2023.08.009_bib38","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/apmr.2002.36959","article-title":"Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system","volume":"83","author":"Cella","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"issue":"9 Suppl","key":"10.1016\/j.ccm.2023.08.009_bib39","first-page":"Ii73","article-title":"Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales","volume":"38","author":"Ware","year":"2000","journal-title":"Med Care"},{"issue":"9 Suppl","key":"10.1016\/j.ccm.2023.08.009_bib40","first-page":"Ii66","article-title":"A\u00a0discussion of item response theory and its applications in health status assessment","volume":"38","author":"Cella","year":"2000","journal-title":"Med Care"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2023.08.009_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11136-007-9197-1","article-title":"Applying item response theory and computer adaptive testing: the challenges for health outcomes assessment","volume":"16","author":"Fayers","year":"2007","journal-title":"Qual Life Res"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.009_bib42","doi-asserted-by":"crossref","first-page":"e38331","DOI":"10.2196\/38331","article-title":"Quality of life and physical activity in 629 individuals with sarcoidosis: prospective, cross-sectional study using smartphones (sarcoidosis app)","volume":"10","author":"Chu","year":"2022","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1164\/rccm.200211-1343OC","article-title":"The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life","volume":"168","author":"Cox","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.009_bib45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","article-title":"Validation and important differences for the sarcoidosis assessment tool. A new patient-reported outcome measure","volume":"191","author":"Judson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib46","first-page":"117","article-title":"Association between physical functions and quality of life in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.009_bib47","doi-asserted-by":"crossref","first-page":"106819","DOI":"10.1016\/j.rmed.2022.106819","article-title":"The association of baseline sarcoidosis measurements with 6-month outcomes that are of interest to patients: results from the On-line Sarcoidosis Assessment Platform Study (OSAP)","volume":"196","author":"Judson","year":"2022","journal-title":"Respir Med"},{"issue":"Pt 3","key":"10.1016\/j.ccm.2023.08.009_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1348\/1359107041557048","article-title":"Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS)","volume":"9","author":"De Vries","year":"2004","journal-title":"Br J Health Psychol"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.009_bib49","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.rmed.2011.05.004","article-title":"Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis","volume":"105","author":"de Kleijn","year":"2011","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13075-016-1151-6","article-title":"Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature","volume":"18","author":"Nikiphorou","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40744-017-0063-5","article-title":"The patient global assessment of disease activity in rheumatoid arthritis: identification of underlying latent factors","volume":"4","author":"Challa","year":"2017","journal-title":"Rheumatol Ther"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00408-021-00455-5","article-title":"The value of a patient global assessment in management of sarcoidosis","volume":"199","author":"Baughman","year":"2021","journal-title":"Lung"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.009_bib53","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3899\/jrheum.090084","article-title":"Test-retest reliability of patient global assessment and physician global assessment in rheumatoid arthritis","volume":"36","author":"Rohekar","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ccm.2023.08.009_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJGM.S334019","article-title":"Physical activity and respiratory muscle strength in patients with sarcoidosis: an observational study","volume":"15","author":"Pescaru","year":"2022","journal-title":"Int J Gen Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.psc.2013.08.001","article-title":"What are the causes of late-life depression?","volume":"36","author":"Aziz","year":"2013","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.ccm.2023.08.009_bib56","doi-asserted-by":"crossref","first-page":"106688","DOI":"10.1016\/j.rmed.2021.106688","article-title":"Differences in disease presentation between men and women with sarcoidosis: a cohort study","volume":"191","author":"Lundkvist","year":"2022","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.009_bib57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11136-010-9813-3","article-title":"Race and preference-based health-related quality of life measures in the United States","volume":"20","author":"Pereira","year":"2011","journal-title":"Qual Life Res"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.009_bib58","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/MLR.0b013e31822ebed9","article-title":"Gender differences in multiple underlying dimensions of health-related quality of life are associated with sociodemographic and socioeconomic status","volume":"49","author":"Cherepanov","year":"2011","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00408-008-9111-9","article-title":"Racial differences in sarcoidosis granuloma density","volume":"187","author":"Burke","year":"2009","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00408-017-0040-3","article-title":"The assessment of cough in a sarcoidosis clinic using a validated instrument and a visual analog scale","volume":"195","author":"Judson","year":"2017","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.ccm.2023.08.009_bib61","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejim.2006.02.024","article-title":"Quality of life in patients with active sarcoidosis in Greece","volume":"17","author":"Antoniou","year":"2006","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12890-021-01761-7","article-title":"FeV1 and BMI influence King's Sarcoidosis Questionnaire score in sarcoidosis patients","volume":"21","author":"Frye","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ccm.2023.08.009_bib63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7525-10-67","article-title":"Distance saturation product predicts health-related quality of life among sarcoidosis patients","volume":"10","author":"Bourbonnais","year":"2012","journal-title":"Health Qual Life Outcome"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib64","first-page":"124","article-title":"Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids","volume":"33","author":"Aggarwal","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.009_bib65","doi-asserted-by":"crossref","first-page":"105936","DOI":"10.1016\/j.rmed.2020.105936","article-title":"Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis","volume":"165","author":"Vis","year":"2020","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib66","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.130.4.989","article-title":"Fatigue is associated with quality of life in sarcoidosis patients","volume":"130","author":"Michielsen","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib67","first-page":"92","article-title":"Fatigue in sarcoidosis: American versus Dutch patients","volume":"26","author":"de Kleijn","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib68","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"Drent","year":"2012","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib69","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1378\/chest.15-0584","article-title":"Interrelationship between sleep-disordered breathing and sarcoidosis","volume":"148","author":"Lal","year":"2015","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/ajrccm.163.2.2004177","article-title":"Depression in sarcoidosis","volume":"163","author":"Chang","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib71","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00754-2020","article-title":"Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study","volume":"7","author":"Alzghoul","year":"2021","journal-title":"ERJ Open Res"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib72","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1378\/chest.07-2952","article-title":"Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue","volume":"133","author":"Lower","year":"2008","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib73","first-page":"183","article-title":"Quality of life in sarcoidosis: a comparison between members of a patient organisation and a random sample","volume":"15","author":"De Vries","year":"1998","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib74","first-page":"57","article-title":"Relationship between perceived stress and sarcoidosis in a Dutch patient population","volume":"21","author":"De Vries","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib75","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.genhosppsych.2011.05.009","article-title":"Fatigue in patients with sarcoidosis, compared with the general population","volume":"33","author":"Hinz","year":"2011","journal-title":"Gen Hosp Psychiatr"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib76","first-page":"60","article-title":"The internal consistency of PRO fatigue instruments in sarcoidosis: superiority of the PFI over the FAS","volume":"30","author":"Kalkanis","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.009_bib77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rmed.2016.05.010","article-title":"Predictors of fatigue in sarcoidosis: the value of exercise testing","volume":"116","author":"Strookappe","year":"2016","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib78","first-page":"14","article-title":"Fatigue in patients with inactive sarcoidosis does not correlate with lung ventilation ability or walking distance. Pilot Study","volume":"83","author":"Zieleznik","year":"2015","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1016\/j.ccm.2023.08.009_bib79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/5584_2014_18","article-title":"Fatigue in sarcoidosis and exercise tolerance, dyspnea, and quality of life","volume":"833","author":"Jastrzebski","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"10.1016\/j.ccm.2023.08.009_bib80","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.rmed.2008.05.001","article-title":"Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis","volume":"102","author":"Gvozdenovic","year":"2008","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib81","first-page":"235","article-title":"The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis","volume":"22","author":"Wagner","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpainsymman.2012.02.016","article-title":"Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial","volume":"45","author":"Lower","year":"2013","journal-title":"J\u00a0Pain Symptom Manag"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib83","first-page":"53","article-title":"Does physical training reduce fatigue in sarcoidosis?","volume":"32","author":"Marcellis","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.009_bib84","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib85","first-page":"147","article-title":"Pulmonary and psychosocial findings at enrollment in the ACCESS study","volume":"22","author":"Yeager","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib86","doi-asserted-by":"crossref","first-page":"e000467","DOI":"10.1136\/bmjresp-2019-000467","article-title":"Psychological burden associated with worse clinical outcomes in sarcoidosis","volume":"6","author":"Sharp","year":"2019","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib87","first-page":"59","article-title":"Quality of life and depressive symptoms in patients suffering from sarcoidosis","volume":"15","author":"Drent","year":"1998","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"7","key":"10.1016\/j.ccm.2023.08.009_bib88","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/resp.12359","article-title":"The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis","volume":"19","author":"de Boer","year":"2014","journal-title":"Respirology (Carlton, Vic)"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000514917","article-title":"The short- and long-term impact of pulmonary rehabilitation in subjects with sarcoidosis: a prospective study and review of the literature","volume":"100","author":"Guber","year":"2021","journal-title":"Respiration"},{"issue":"8","key":"10.1016\/j.ccm.2023.08.009_bib90","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.21037\/jtd-21-462","article-title":"Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis","volume":"13","author":"Bloem","year":"2021","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.ccm.2023.08.009_bib91","doi-asserted-by":"crossref","first-page":"633005","DOI":"10.3389\/fnbeh.2021.633005","article-title":"Neuropsychobiological fingerprints of chronic fatigue in sarcoidosis","volume":"15","author":"Kettenbach","year":"2021","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.ccm.2023.08.009_bib92","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.rmed.2018.03.021","article-title":"Sleep disturbance and symptom burden in sarcoidosis","volume":"144s","author":"Benn","year":"2018","journal-title":"Respir Med"},{"issue":"9","key":"10.1016\/j.ccm.2023.08.009_bib93","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00007611-199709000-00010","article-title":"Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis?","volume":"90","author":"Highland","year":"1997","journal-title":"South Med J"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib94","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"Lofgren's syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"10.1016\/j.ccm.2023.08.009_bib95","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.0b013e3181bacf05","article-title":"Intraepidermal nerve fiber density and its application in sarcoidosis","volume":"73","author":"Bakkers","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ccm.2023.08.009_bib96","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment","volume":"126","author":"Tavee","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.08.009_bib97","series-title":"Sarcoidosis: a clinician\u2019s guide","first-page":"167","article-title":"Parasarcoidosis syndromes","author":"Judson","year":"2019"},{"issue":"4","key":"10.1016\/j.ccm.2023.08.009_bib98","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7224\/1537-2073-13.4.163","article-title":"Effects of meditation on pain and quality of life in multiple sclerosis and peripheral neuropathy: a pilot study","volume":"13","author":"Tavee","year":"2011","journal-title":"International journal of MS care"},{"issue":"10","key":"10.1016\/j.ccm.2023.08.009_bib99","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2169\/internalmedicine.54.3702","article-title":"Neurological symptoms of sarcoidosis-induced small fiber neuropathy effectively relieved with high-dose steroid pulse therapy","volume":"54","author":"Saito","year":"2015","journal-title":"Intern med (Tokyo, Japan)"},{"key":"10.1016\/j.ccm.2023.08.009_bib100","first-page":"92","article-title":"Fatigue, quality of life and health status in sarcoidosis","volume":"32","author":"De Vries","year":"2005","journal-title":"Eur Respir Monogr"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib101","first-page":"219","article-title":"Clinical impact of inspiratory muscle impairment in sarcoidosis","volume":"21","author":"Brancaleone","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib102","first-page":"51","article-title":"The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis","volume":"23","author":"Judson","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.ccm.2023.08.009_bib103","first-page":"1430","article-title":"Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study","volume":"18","author":"Heij","year":"2012","journal-title":"Mol Med (Cambridge, Mass.)"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1300\/J013v30n02_07","article-title":"Gender differences in sarcoidosis: symptoms, quality of life, and medical consumption","volume":"30","author":"De Vries","year":"1999","journal-title":"Women Health"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0300-2977(98)00148-X","article-title":"Impairment of quality of life: rheumatoid arthritis versus sarcoidosis","volume":"54","author":"Wirnsberger","year":"1999","journal-title":"Neth J Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.08.009_bib106","first-page":"1295","article-title":"The minimal clinical important difference in the World Health Organization Quality of Life instrument--100","volume":"21","author":"Den Oudsten","year":"2013","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib107","first-page":"701","article-title":"WHOQOL-bREF questionnaire as a measure of quality of life in sarcoidosis","volume":"37","author":"Alilovic","year":"2013","journal-title":"Coll Antropol"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib108","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1183\/09031936.00117710","article-title":"Exercise capacity, muscle strength and fatigue in sarcoidosis","volume":"38","author":"Marcellis","year":"2011","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib109","first-page":"837","article-title":"Health related quality of life regarding to gender in sarcoidosis","volume":"33","author":"Dudvarski-Ilic","year":"2009","journal-title":"Coll Antropol"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib110","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1038\/s41598-021-89383-1","article-title":"Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire","volume":"11","author":"Gwadera","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ccm.2023.08.009_bib111","first-page":"e2021035","article-title":"Roflumilast (Daliresp\u00ae) to reduce acute pulmonary events in fibrotic sarcoidosis: a multi-center, double blind, placebo controlled, randomized clinical trial","volume":"38","author":"Baughman","year":"2021","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2023.08.009_bib112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.06-2822","article-title":"Six-minute walk test and health status assessment in sarcoidosis","volume":"132","author":"Baughman","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.08.009_bib113","doi-asserted-by":"crossref","first-page":"100669","DOI":"10.1016\/j.conctc.2020.100669","article-title":"Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosis","volume":"20","author":"Hade","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib114","first-page":"158","article-title":"Predictors of cough-specific and generic quality of life in sarcoidosis patients","volume":"37","author":"Gvozdenovic","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1016\/j.ccm.2023.08.009_bib115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.psychres.2008.04.022","article-title":"An assessment of the CES-D scale factor structure in black women: The Black Women\u2019s Health Study","volume":"168","author":"Makambi","year":"2009","journal-title":"Psychiatr Res"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:16:23Z","timestamp":1759454183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0272523123000783"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.009","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-Related Quality of Life Assessment in Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}